Clinical trial Recruiting at 1 site Observational Ages 1 Year and up

Dermoscopy and Histopathology Patterns in Pigmented Skin Lesions

Official title: Dermoscopic and Histopathological Patterns of Pigmented Skin Lesions: A Cross-sectional Analytical Study.

Run by Sohag University · NCT07863076 · Data updated 2026-11-12

This study tests how dermoscopic patterns align with clinical and histopathological diagnoses in people with pigmented skin lesions.

Quick facts

Study typeObservational
Ages1 Year and up
SexAll
Enrollment400 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedOctober 31, 2027
Study endsDecember 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07863076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with clinically diagnosed or suspected pigmented skin lesions across all body sites who can provide usable dermoscopic images and, when possible, histopathology data.

Probably not a fit

Patients with lesions that remain benign or where histopathology is not available may not experience a diagnostic benefit from dermoscopy alone.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study describes the characteristic dermoscopic features of pigmented skin lesions, including melanocytic and non-melanocytic types, seen at Sohag University Hospitals. It aims to correlate dermoscopic findings with clinical evaluations and available histopathology to improve diagnostic understanding. The project also evaluates how well dermoscopy distinguishes benign from malignant pigmented skin lesions. Participants include individuals with clinically diagnosed or suspected pigmented nevi, seborrheic keratosis, pigmented actinic keratosis, pigmented basal cell carcinoma, and suspected melanoma, across facial, acral, mucosal, and trunk sites. Exclusion criteria include poor-quality dermoscopic images and lesions where histopathology cannot be obtained.

Why it matters

Potential benefit: If successful, dermoscopy could help clinicians more accurately differentiate benign from malignant pigmented lesions, potentially guiding management and biopsy decisions.

How similar studies have gone: Previous work has shown that dermoscopy can improve diagnostic accuracy for pigmented skin lesions in other settings, supporting the potential usefulness of this approach here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Patients with clinically diagnosed or suspected pigmented skin lesions including; pigmented nevi (typical and atypical), seborrheic keratosis, pigmented actinic keratosis, pigmented BCC, suspected melanoma

  * All facial, acral, mucosal and trunk pigmented lesions will be included

Exclusion Criteria:

* • Poor quality dermoscopic images that are unsuitable for interpretation.

  * Lesions with difficulty in obtaining histopathological specimens

Where it's running

  • Sohag University Hospitals
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.